Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.87 | €22.78 | 109.621% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €68.50 | €73.92 | 7.912% |
| Molina Healthcare | 11 | 1 | 1 | 1 | €319.90 | €359.93 | 12.515% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.40 | €82.93 | 100.317% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €127.20 | €147.62 | 16.050% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €75.64 | €85.68 | 13.279% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| CONMED Corp. | 11 | 1 | 3 | 0 | €60.00 | €109.59 | 82.642% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.23 | €3.70 | 201.058% |
| Integer Hldg | 1 | 0 | 0 | 0 | €117.00 | - | - |
| Amedisys Inc. | 13 | 0 | 1 | 0 | €83.50 | €92.26 | 10.491% |
| Icon plc | 18 | 0 | 6 | 0 | €288.20 | €318.99 | 10.685% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| LivaNova plc | 7 | 0 | 2 | 0 | €51.00 | €64.66 | 26.782% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €87.50 | €124.85 | 42.683% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €58.50 | €75.80 | 29.573% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.05 | €137.63 | 8.331% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €91.00 | €95.79 | 5.269% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.26 | €55.00 | 5.243% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €17.30 | €45.10 | 160.665% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.81 | - | - |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |